OP Asset Management Ltd Invests $1.51 Million in Astera Labs, Inc. $ALAB

OP Asset Management Ltd acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 1st quarter, HoldingsChannel.com reports. The firm acquired 13,785 shares of the company’s stock, valued at approximately $1,511,000.

A number of other institutional investors have also recently made changes to their positions in the business. Atreides Management LP increased its position in Astera Labs by 2,496.6% during the 4th quarter. Atreides Management LP now owns 1,611,194 shares of the company’s stock valued at $268,038,000 after buying an additional 1,549,144 shares in the last quarter. Amundi grew its stake in shares of Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after acquiring an additional 1,319,643 shares during the last quarter. BNP Paribas Financial Markets grew its stake in shares of Astera Labs by 577.3% during the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after acquiring an additional 960,899 shares during the last quarter. Artisan Partners Limited Partnership acquired a new position in shares of Astera Labs during the fourth quarter valued at about $148,980,000. Finally, Goldman Sachs Group Inc. increased its holdings in shares of Astera Labs by 189.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock valued at $218,419,000 after acquiring an additional 858,693 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Activity at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 796 shares of the company’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $291.03, for a total value of $231,659.88. Following the completion of the transaction, the general counsel owned 103,343 shares in the company, valued at approximately $30,075,913.29. This represents a 0.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director owned 75,688 shares in the company, valued at $26,882,106.96. This represents a 11.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,161,942 shares of company stock valued at $460,115,294 in the last quarter. 10.40% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on ALAB shares. JPMorgan Chase & Co. lifted their target price on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Bank of America upped their price target on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research note on Tuesday, June 23rd. Morgan Stanley upped their price target on shares of Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Stifel Nicolaus raised their price target on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. Finally, Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $265.75.

Astera Labs Stock Up 16.4%

Astera Labs stock opened at $455.96 on Tuesday. The stock has a 50-day moving average price of $294.90 and a 200 day moving average price of $198.27. The company has a market capitalization of $78.16 billion, a price-to-earnings ratio of 308.08, a price-to-earnings-growth ratio of 4.50 and a beta of 3.94. Astera Labs, Inc. has a 52 week low of $85.85 and a 52 week high of $456.76.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the prior year, the company earned $0.33 EPS. Astera Labs’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Research analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.